About Us
Cancilico: Pioneering AI in Image-Based Diagnostics
At Cancilico, we are at the forefront of integrating artificial intelligence into image-based diagnostics. Founded by a dynamic team of experts in business informatics, computer science, biology, and medicine, we are dedicated to transforming the way diseases such as hematological cancers are diagnosed and studied. Our mission is to harness the power of AI to revolutionize medical diagnostics, making it more accurate, efficient, and accessible.
Our journey began with a shared vision: to address the critical need for innovation in the diagnosis of blood-related diseases. Recognizing the limitations of traditional methods, we embarked on creating AI-driven solutions that could automate and enhance this vital process. The result is a suite of advanced, user-friendly software tools that are reshaping the landscape of image-based diagnostics and research.
At the heart of Cancilico lies a commitment to improving patient outcomes and advancing medical research. Our technology not only speeds up diagnostic processes but also offers unparalleled accuracy, helping to unlock new possibilities in treatment and research. By automating routine tasks, we free up valuable time for medical professionals, allowing them to focus on more complex aspects of patient care.
We are driven by the potential to make a real difference in the lives of patients and the medical community. Through continuous innovation and collaboration, we are setting new standards in healthcare technology and paving the way for a healthier future.
Team
Markus Badstübner (CEO)
Technology transfer enthusiast focusing on bringing research in AI technology from lab to the market
Sebastian Riechert (CAIO)
Tim Schmittmann (CTO)
Technology allrounder with expertise in full-stack application development, modern web technologies, big data management, deep learning frameworks, DevOps, agile methodologies, and medical imaging software development
Katja Siegert (Head, Q&RA)
Accomplished Quality & Regulatory Affairs Manager adept in international medical device registration, standards compliance, quality management and quality control
Dr.-Ing. Karsten Wendt (Soft-Tech Consultant)
Experienced Computer Scientist with expertise in machine learning, digital health, and data-driven design along with a strong background in data science and industry 4.0
Dr. med. Jan Moritz Middeke (CMO)
Distinguished Senior Physician specializing in internal medicine, hematology, and oncology. Expertise in stem cell transplantation, acute leukemias, and chronic lymphocytic leukemia (CLL) with a profound commitment to advancing treatments in these critical areas of medicine
Dr. med. Jan-Niklas Eckardt (CSO)
Clinician-Scientist and Resident in Hematology and Medical Oncology striving to shape the emerging field of digital personalized oncology
Dr. Tanmaya Joshi (CPO)
Seasoned project management professional with a knack for solving problems, along with a passion for driving scientific innovations and creating solutions from the ground up
Cancilico Board Members
Prof. em. Dr. med. Gerhard Ehninger
A serial entrepreneur, renowned clinician, researcher and former Head of Hematology & Oncology at University Hospital Carl Gustav Carus Dresden
David Rittrich
Architect for data-driven businesses with a strong background in cloud transformation and focus on data engineering
Prof. Dr. med. Jochen Hampe
Director of Medical Clinic I at University Hospital Carl Gustav Carus and Professor for Internal Medicine and Gastroenterology at Dresden University of Technology
Cancilico Advisory Board Members
Dr. med. Stefani Parmentier
Distinguished Hematologist and leading Physician at the Claraspital Basel Tumor Center
Prof. Jakob N. Kather
Professor for Clinical Artificial Intelligence at Dresden University of Technology focussing on deep learning for immunotherapy biomarkers in cancer
Prof. Dr. med. Martin Bornhäuser
Director of Medical Clinic I at University Hospital Carl Gustav Carus and at the National Center for Tumor Diseases Dresden, and Professor for Hematology/Oncology
Prof. Stephen Gilbert
Professor at Dresden University of Technology (Else Kröner Fresenius Center for Digital Health – EKFZ) with more than 15 years of experience in regulatory science and expertise in medical and IVD regulations
Dr. med. Katja Sockel
Senior Physician for Hematology/Oncology at Carl Gustav Carus University Hospital Dresden and Deputy Head of the Laboratory for Hematologic Cytology with clinical & research focus in myeloid neoplasia